The fact that yeast ortholog of the human AD risk factor, phosphatidylinositol-binding clathrin assembly protein (PICALM), reduces oligomerization of Aβ42-MRF indicates that Aβ42-MRF reporter system is suitable for identifying compounds that could be developed into therapies that prevent or arrest AD [129]. Here, MYRF is linked to Alzheimer disease.